Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition

Journal of Lipid Research

Volumn 46, Issue 2, 2005, Pages 201-210

  Ghesquiere, Stijn A I ^a   Gijbels, Marion J J ^a   Anthonsen, Marit ^b   Van Gorp, Patrick J J ^a   Van Der Made, Ingeborg ^a   Johansen, Berit ^b   Hofker, Marten H ^a   De Winther, Menno P J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Atherogenesis; Inflammation; Lipid modification; Secretory phospholipase A2

Indexed keywords

LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHRONIC INFLAMMATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME MODIFICATION; ENZYME REGULATION; FEMALE; FIBROBLAST; HUMAN; LIPID DIET; MACROPHAGE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SMOOTH MUSCLE FIBER; SPLA 2 IIA GENE; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD11B; ARTERIOSCLEROSIS; BLOTTING, NORTHERN; BONE MARROW TRANSPLANTATION; CHOLESTEROL; COLLAGEN; FIBROBLASTS; FOAM CELLS; HUMANS; IN SITU NICK-END LABELING; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, TRANSGENIC; MODELS, GENETIC; MYOCYTES, SMOOTH MUSCLE; NECROSIS; PHENOTYPE; PHOSPHOLIPASES; PHOSPHOLIPASES A; PROMOTER REGIONS (GENETICS); RECEPTORS, LDL; TIME FACTORS;

EID: 13944272572     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400253-JLR200     Document Type: Article

References (47)

1. Williams, K. J., and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15: 551-561.
2. Glass, C. K., and J. L. Witztum. 2001. Atherosclerosis. The road ahead. Cell. 104: 503-516.
3. Lusis, A. J. 2000. Atherosclerosis. Nature. 407: 233-241.
4. Libby, P., P. M. Ridker, and A. Maseri. 2002. Inflammation and atherosclerosis. Circulation. 105: 1135-1143.
5. Anthonsen, M. W., D. Stengel, D. Hourton, E. Ninio, and B. Johansen. 2000. Mildly oxidized LDL induces expression of group IIa secretory phospholipase A(2) in human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 20: 1276-1282.
6. Menschikowski, M., M. Kasper, P. Lattke, A. Schiering, S. Schiefer, H. Stockinger, and W. Jaross. 1995. Secretory group II phospholipase A2 in human atherosclerotic plaques. Atherosclerosis. 118: 173-181.
7. Elinder, L. S., A. Dumitrescu, P. Larsson, U. Hedin, J. Frostegard, and H. E. Claesson. 1997. Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall. Arterioscler. Thromb. Vasc. Biol. 17: 2257-2263.
8. Six, D. A., and E. A. Dennis. 2000. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta. 1488: 1-19.
9. Dennis, E. A. 1997. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22: 1-2.
10. Hurt-Camejo, E., and G. Camejo. 1997. Potential involvement of type II phospholipase A2 in atherosclerosis. Atherosclerosis. 132: 1-8.
11. Sartipy, P., B. Johansen, G. Camejo, B. Rosengren, G. Bondjers, and E. Hurt-Camejo. 1996. Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity. J. Biol. Chem. 271: 26307-26314.
12. Flood, C., M. Gustafsson, R. E. Pitas, L. Arnabokli, R. L. Walzem, and J. Boren. 2004. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100. Arterioscler. Thromb. Vasc. Biol. 24: 564-570.
13. Hurt-Camejo, E., G. Camejo, and P. Sartipy. 2000. Phospholipase A2 and small, dense low-density lipoprotein. Curr. Opin. Lipidol. 11: 465-471.
14. Sartipy, P., G. Camejo, L. Svensson, and E. Hurt-Camejo. 1999. Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans. J. Biol. Chem. 274: 25913-25920.
15. Wooton-Kee, C. R., B. B. Boyanovsky, M. S. Nasser, W. J. de Villiers, and N. R. Webb. 2004. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation. Arterioscler. Thromb. Vasc. Biol. 24: 762-767.
16. Sartipy, P., G. Bondjers, and E. Hurt-Camejo. 1998. Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes. Arterioscler. Thromb. Vasc. Biol. 18: 1934-1941.
17. Hakala, J. K., K. Oorni, M. O. Pentikainen, E. Hurt-Camejo, and P. T. Kovanen. 2001. Lipolysis of LDL by human secretory phospholipase A(2) induces particle fusion and enhances the retention of LDL to human aortic proteoglycans. Arterioscler. Thromb. Vasc. Biol. 21: 1053-1058.
18. Oestvang, J., D. Bonnefont-Rousselot, E. Ninio, J. K. Hakala, B. Johansen, and M. W. Anthonsen. 2004. Modification of LDL with human secretory phospholipase A(2) or sphingomyelinase promotes its arachidonic acid-releasing propensity. J. Lipid Res. 45: 831-838.
19. Grass, D. S., R. H. Felkner, M. Y. Chiang, R. E. Wallace, T. J. Nevalainen, C. F. Bennett, and M. E. Swanson. 1996. Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J. Clin. Invest. 97: 2233-2241.
20. Ivandic, B., L. W. Castellani, X. P. Wang, J. H. Qiao, M. Mehrabian, M. Navab, A. M. Fogelman, D. S. Grass, M. E. Swanson, M. C. de Beer, F. de Beer, and A. J. Lusis. 1999. Role of group II secretory phospholipase A2 in atherosclerosis. I. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. Arterioscler. Thromb. Vasc. Biol. 19: 1284-1290.
21. Webb, N. R., M. A. Bostrom, S. J. Szilvassy, D. R. van der Westhuyzen, A. Daugherty, and F. C. de Beer. 2003. Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23: 263-268.
22. Dziennis, S., R. A. Van Etten, H. L. Pahl, D. L. Morris, T. L. Rothstein, C. M. Blosch, R. M. Perlmutter, and D. G. Tenen. 1995. The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood. 85: 319-329.
23. Kramer, R. M., C. Hession, B. Johansen, G. Hayes, P. McGray, E. P. Chow, R. Tizard, and R. B. Pepinsky. 1989. Structure and properties of a human non-pancreatic phospholipase A2. J. Biol. Chem. 264: 5768-5775.
24. Hogan, B., R. Beddington, F. Constantini, and E. Lacy. 1994. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press.
25. Kennedy, B. P., P. Payette, J. Mudgett, P. Vadas, W. Pruzanski, M. Kwan, C. Tang, D. E. Rancourt, and W. A. Cromlish. 1995. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J. Biol. Chem. 270: 22378-22385.
26. Ishibashi, S., M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92: 883-893.
27. Kanters, E., M. Pasparakis, M. J. Gijbels, M. N. Vergouwe, I. Partouns-Hendriks, R. J. Fijneman, B. E. Clausen, I. Forster, M. M. Kockx, K. Rajewsky, G. Kraal, M. H. Hofker, and M. P. de Winther. 2003. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 112: 1176-1185.
28. Hurt-Camejo, E., S. Andersen, R. Standal, B. Rosengren, P. Sartipy, E. Stadberg, and B. Johansen. 1997. Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 17: 300-309.
29. de Winther, M. P., K. W. van Dijk, B. J. van Vlijmen, M. J. Gijbels, J. J. Heus, E. R. Wijers, A. C. van den Bos, M. Breuer, R. R. Frants, L. M. Havekes, and M. H. Hofker. 1999. Macrophage specific overexpression of the human macrophage scavenger receptor in transgenic mice, using a 180-kb yeast artificial chromosome, leads to enhanced foam cell formation of isolated peritoneal macrophages. Atherosclerosis. 147: 339-347.
30. Senti, M., M. Tomas, M. Fito, T. Weinbrenner, M. I. Covas, J. Sala, R. Masia, and J. Marrugat. 2003. Antioxidant paraoxonase 1 activity in the metabolic syndrome. J. Clin. Endocrinol. Metab. 88: 5422-5426.
31. Mackness, M. I., D. Harty, D. Bhatnagar, P. H. Winocour, S. Arrol, M. Ishola, and P. N. Durrington. 1991. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis. 86: 193-199.
32. Nevalainen, T. J., F. Marki, P. T. Kortesuo, M. G. Grutter, S. Di Marco, and A. Schmitz. 1993. Synovial type (group II) phospholipase A2 in cartilage. J. Rheumatol. 20: 325-330.
33. Lauber, K., E. Bohn, S. M. Krober, Y. J. Xiao, S. G. Blumenthal, R. K. Lindemann, P. Marini, C. Wiedig, A. Zobywalski, S. Baksh, Y. Xu, I. B. Autenrieth, K. Schulze-Osthoff, C. Belka, G. Stuhler, and S. Wesselborg. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 113: 717-730.
34. Nevalainen, T. J., V. J. Laine, and D. S. Grass. 1997. Expression of human group II phospholipase A2 in transgenic mice. J. Histochem. Cytochem. 45: 1109-1119.
35. Sartipy, P., B. Johansen, K. Gasvik, and E. Hurt-Camejo. 2000. Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesions. Circ. Res. 86: 707-714.
36. Murakami, M., T. Kambe, S. Shimbara, S. Yamamoto, H. Kuwata, and I. Kudo. 1999. Functional association of type IIA secretory phospholipase A(2) with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway. J. Biol. Chem. 274: 29927-29936.
37. Kovanen, P. T., and M. O. Pentikainen. 1999. Decorin links low-density lipoproteins (LDL) to collagen: a novel mechanism for retention of LDL in the atherosclerotic plaque. Trends Cardiovasc. Med. 9: 86-91.
38. Jaross, W., R. Eckey, and M. Menschikowski. 2002. Biological effects of secretory phospholipase A(2) group IIA on lipoproteins and in atherogenesis. Eur. J. Clin. Invest. 32: 383-393.
39. Skalen, K., M. Gustafsson, E. K. Rydberg, L. M. Hulten, O. Wiklund, T. L. Innerarity, and J. Boren. 2002. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 417: 750-754.
40. Paananen, K., J. Saarinen, A. Annila, and P. T. Kovanen. 1995. Proteolysis and fusion of low density lipoprotein particles strengthen their binding to human aortic proteoglycans. J. Biol. Chem. 270: 12257-12262.
41. Oorni, K., M. O. Pentikainen, A. Annila, and P. T. Kovanen. 1997. Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans. Dependence on oxidative modification of the lysine residues. J. Biol. Chem. 272: 21303-21311.
42. Mayer, J. M., V. J. Laine, S. Kolodziej, T. J. Nevalainen, and H. G. Beger. 2002. Acute pancreatitis in transgenic mice expressing human group IIA phospholipase A2. Pancreas. 25: 188-191.
43. Weitkamp, B., P. Cullen, G. Plenz, H. Robenek, and J. Rauterberg. 1999. Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque. FASEB J. 13: 1445-1457.
44. Steed, D. L. 2003. Wound-healing trajectories. Surg. Clin. North Am. 83: 547-555 (vi-vii).
45. Gilroy, D. W., J. Newson, P. Sawmynaden, D. A. Willoughby, and J. D. Croxtall. 2004. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J. 18: 489-498.
46. Levy, B. D., C. B. Clish, B. Schmidt, K. Gronert, and C. N. Serhan. 2001. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2: 612-619.
47. Gilroy, D. W., P. R. Colville-Nash, D. Willis, J. Chivers, M. J. Paul-Clark, and D. A. Willoughby. 1999. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5: 698-701.